Thus, we suggest that the ameliorative action of SE-EE on oxidative stress and cholinergic impairment might also be substantially achieved through the modulation of CREB/BDNF signalling in scopolamine-induced AD-like mice. This evidence concerns the gene BDNF and Alzheimer disease.